Clinical trials
Hypertension trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
278 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 4 |
| 2003 | 11 |
| 2004 | 15 |
| 2005 | 10 |
| 2006 | 12 |
| 2007 | 12 |
| 2008 | 15 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 14 |
| 2012 | 17 |
| 2013 | 14 |
| 2014 | 13 |
| 2015 | 11 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 16 |
| 2019 | 12 |
| 2020 | 5 |
| 2021 | 17 |
| 2022 | 10 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 10 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 181 |
| Unknown status | 34 |
| Terminated | 22 |
| Recruiting | 19 |
| Active, not recruiting | 11 |
| Withdrawn | 5 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 15 |
| University of Alberta | 14 |
| Sunnybrook Health Sciences Centre | 13 |
| Boehringer Ingelheim | 11 |
| Ottawa Hospital Research Institute | 11 |
| University of Calgary | 11 |
| AstraZeneca | 7 |
| Hamilton Health Sciences Corporation | 7 |
| University Health Network, Toronto | 7 |
| John Sievenpiper | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 278 |
| Diabetes Mellitus | 59 |
| Cardiovascular Diseases | 49 |
| Diabetes Mellitus, Type 2 | 34 |
| Obesity | 30 |
| Stroke | 24 |
| Dyslipidemias | 23 |
| Heart Failure | 23 |
| Renal Insufficiency, Chronic | 21 |
| Metabolic Syndrome | 16 |
Trials
Showing 1 to 25 of 278. Each trial links to its page on Pharma Observatory.
178 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.